Literature DB >> 4889097

Dysthyroid eye disease. A trial of guanethidine eye drops.

A N Bowden, F C Rose.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4889097      PMCID: PMC1207307          DOI: 10.1136/bjo.53.4.246

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

1.  Adrenergic blockade and the eye signs of thyrotoxicosis.

Authors:  J M Sneddon; P Turner
Journal:  Lancet       Date:  1966-09-03       Impact factor: 79.321

2.  Investigation of endocrine exophthalmos.

Authors:  A N Bowden; F C Ross
Journal:  Proc R Soc Med       Date:  1969-01

3.  Topical guanethidine therapy for endocrine lid retraction.

Authors:  A J Gay; M A Wolkstein
Journal:  Arch Ophthalmol       Date:  1966-09

4.  Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction.

Authors:  A L Crombie; A A Lawson
Journal:  Br Med J       Date:  1967-12-09
  4 in total
  4 in total

1.  Critical study of 5 per cent guanethidine in ocular manifestations of Graves's disease.

Authors:  N E Cartlidge; A L Crombie; J Anderson; R Hall
Journal:  Br Med J       Date:  1969-12-13

2.  Retraction of the eyelids secondary to thyroid ophthalmopathy--its surgical correction with sclera and the fate of the graft.

Authors:  J C Flanagan
Journal:  Trans Am Ophthalmol Soc       Date:  1980

3.  Brachymorphism-onychodysplasia-dysphalangism syndrome.

Authors:  A Verloes; D Bonneau; O Guidi; M Berthier; D Oriot; L Van Maldergem; L Koulischer
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

4.  Neuro-ophthalmology.

Authors:  F C Rose
Journal:  J R Coll Physicians Lond       Date:  1974-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.